• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Optimal revascularization for left main coronary artery disease-coronary artery bypass grafting versus percutaneous coronary intervention.

作者信息

Bostock Ian C, McCullough Jock N, Iribarne Alexander

机构信息

Section of Cardiac Surgery, Dartmouth-Hitchcock Medical Center, Lebanon, NH, USA.

The Dartmouth Institute for Health Policy and Clinical Practice, Lebanon, NH, USA.

出版信息

J Thorac Dis. 2017 May;9(5):1171-1173. doi: 10.21037/jtd.2017.04.24.

DOI:10.21037/jtd.2017.04.24
PMID:28616264
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5465172/
Abstract
摘要

相似文献

1
Optimal revascularization for left main coronary artery disease-coronary artery bypass grafting versus percutaneous coronary intervention.左主干冠状动脉疾病的最佳血运重建——冠状动脉搭桥术与经皮冠状动脉介入治疗的比较
J Thorac Dis. 2017 May;9(5):1171-1173. doi: 10.21037/jtd.2017.04.24.
2
Current percutaneous coronary intervention and coronary artery bypass grafting practices for three-vessel and left main coronary artery disease. Insights from the SYNTAX run-in phase.当前针对三支血管病变及左主干冠状动脉疾病的经皮冠状动脉介入治疗和冠状动脉旁路移植术实践。来自SYNTAX导入期的见解。
Eur J Cardiothorac Surg. 2006 Apr;29(4):486-91. doi: 10.1016/j.ejcts.2006.01.047. Epub 2006 Feb 23.
3
Percutaneous Coronary Intervention of Left Main Disease: Pre- and Post-EXCEL (Evaluation of XIENCE Everolimus Eluting Stent Versus Coronary Artery Bypass Surgery for Effectiveness of Left Main Revascularization) and NOBLE (Nordic-Baltic-British Left Main Revascularization Study) Era.左主干疾病的经皮冠状动脉介入治疗：EXCEL（评价依维莫司洗脱支架 XIENCE 与冠状动脉旁路移植术治疗左主干血运重建效果）和 NOBLE（北欧-波罗的海-英国左主干血运重建研究）时代之前和之后。
Circ Cardiovasc Interv. 2017 Jun;10(6). doi: 10.1161/CIRCINTERVENTIONS.117.004792.
4
Stroke Rates Following Surgical Versus Percutaneous Coronary Revascularization.冠状动脉血运重建术后卒率比较：外科手术与经皮冠状动脉介入治疗。
J Am Coll Cardiol. 2018 Jul 24;72(4):386-398. doi: 10.1016/j.jacc.2018.04.071.
5
A comparative study of bypass versus percutaneous intervention for left main disease.左主干病变搭桥术与经皮介入治疗的对比研究。
Tunis Med. 2019 Apr;97(4):533-540.
6
Long-term clinical outcomes after percutaneous coronary intervention versus coronary artery bypass grafting for ostial/midshaft lesions in unprotected left main coronary artery from the DELTA registry: a multicenter registry evaluating percutaneous coronary intervention versus coronary artery bypass grafting for left main treatment.DELTA 注册研究：非保护左主干冠状动脉开口/中段病变行经皮冠状动脉介入治疗与冠状动脉旁路移植术的长期临床结果：多中心注册研究评估左主干病变的经皮冠状动脉介入治疗与冠状动脉旁路移植术治疗
JACC Cardiovasc Interv. 2014 Apr;7(4):354-61. doi: 10.1016/j.jcin.2013.11.014. Epub 2014 Mar 14.
7
Coronary artery bypass graft surgery versus percutaneous coronary intervention in unprotected left main coronary artery disease: A systematic review.冠状动脉旁路移植术与经皮冠状动脉介入治疗在无保护左主干冠状动脉疾病中的比较：一项系统评价。
Rev Cardiovasc Med. 2020 Mar 30;21(1):65-73. doi: 10.31083/j.rcm.2020.01.590.
8
Left Main Percutaneous Coronary Intervention Versus Coronary Artery Bypass Grafting in Patients With Prior Cerebrovascular Disease: Results From the EXCEL Trial.左主干经皮冠状动脉介入治疗与冠状动脉旁路移植术治疗有既往脑血管疾病患者的比较：EXCEL 试验结果。
JACC Cardiovasc Interv. 2018 Dec 24;11(24):2441-2450. doi: 10.1016/j.jcin.2018.09.008.
9
Long-term clinical outcomes after percutaneous coronary intervention for ostial/mid-shaft lesions versus distal bifurcation lesions in unprotected left main coronary artery: the DELTA Registry (drug-eluting stent for left main coronary artery disease): a multicenter registry evaluating percutaneous coronary intervention versus coronary artery bypass grafting for left main treatment.经皮冠状动脉介入治疗开口/中段病变与无保护左主干冠状动脉分叉病变的长期临床结局：DELTA 注册研究（左主干冠状动脉疾病药物洗脱支架）：一项多中心注册研究，评估经皮冠状动脉介入治疗与冠状动脉旁路移植术治疗左主干的疗效。
JACC Cardiovasc Interv. 2013 Dec;6(12):1242-9. doi: 10.1016/j.jcin.2013.08.005.
10
Comparison of 30-day outcomes of coronary artery bypass grafting surgery verus hybrid coronary revascularization stratified by SYNTAX and euroSCORE.比较 SYNTAX 和 euroSCORE 分层的冠状动脉旁路移植术与杂交冠状动脉血运重建术的 30 天结局。
J Thorac Cardiovasc Surg. 2013 Apr;145(4):1004-1012. doi: 10.1016/j.jtcvs.2012.03.062. Epub 2012 Apr 25.

本文引用的文献

1
Why NOBLE and EXCEL Are Consistent With Each Other and With Previous Trials.为何NOBLE试验与EXCEL试验相互一致且与先前试验一致。
Circulation. 2017 Feb 28;135(9):822-824. doi: 10.1161/CIRCULATIONAHA.116.027159.
2
Drug-eluting stent placement versus coronary artery bypass surgery for unprotected left main coronary artery disease: A meta-analysis of randomized controlled trials.药物洗脱支架置入术与冠状动脉旁路移植术治疗无保护左主干冠状动脉疾病：一项随机对照试验的荟萃分析。
J Card Surg. 2017 Feb;32(2):70-79. doi: 10.1111/jocs.13090. Epub 2017 Jan 12.
3
Percutaneous Coronary Intervention Using Drug-Eluting Stents Versus Coronary Artery Bypass Grafting for Unprotected Left Main Coronary Artery Stenosis: A Meta-Analysis of Randomized Trials.药物洗脱支架经皮冠状动脉介入治疗与冠状动脉旁路移植术治疗无保护左主干冠状动脉狭窄的比较：一项随机试验的荟萃分析
Circ Cardiovasc Interv. 2016 Dec;9(12). doi: 10.1161/CIRCINTERVENTIONS.116.004729.
4
Percutaneous coronary angioplasty versus coronary artery bypass grafting in treatment of unprotected left main stenosis (NOBLE): a prospective, randomised, open-label, non-inferiority trial.经皮冠状动脉介入治疗与冠状动脉旁路移植术治疗无保护左主干狭窄（NOBLE）：一项前瞻性、随机、开放标签、非劣效性试验。
Lancet. 2016 Dec 3;388(10061):2743-2752. doi: 10.1016/S0140-6736(16)32052-9. Epub 2016 Oct 31.
5
Everolimus-Eluting Stents or Bypass Surgery for Left Main Coronary Artery Disease.依维莫司洗脱支架或旁路移植术治疗左主干冠状动脉疾病。
N Engl J Med. 2016 Dec 8;375(23):2223-2235. doi: 10.1056/NEJMoa1610227. Epub 2016 Oct 31.
6
Coronary bypass surgery versus stenting in multivessel disease involving the proximal left anterior descending coronary artery.在涉及左冠状动脉前降支近端的多支血管病变中，冠状动脉搭桥手术与支架置入术的比较
Heart. 2017 Mar;103(6):428-433. doi: 10.1136/heartjnl-2016-309720. Epub 2016 Sep 20.
7
Left Main Coronary Artery Disease: Secular Trends in Patient Characteristics, Treatments, and Outcomes.左主干冠状动脉疾病：患者特征、治疗方法和预后的长期变化趋势。
J Am Coll Cardiol. 2016 Sep 13;68(11):1233-1246. doi: 10.1016/j.jacc.2016.05.089.
8
Coronary-Artery Bypass Surgery in Patients with Ischemic Cardiomyopathy.缺血性心肌病患者的冠状动脉搭桥手术
N Engl J Med. 2016 Apr 21;374(16):1511-20. doi: 10.1056/NEJMoa1602001. Epub 2016 Apr 3.
9
CABG Versus PCI: Greater Benefit in Long-Term Outcomes With Multiple Arterial Bypass Grafting.冠状动脉搭桥术与经皮冠状动脉介入治疗：多支动脉搭桥术在长期预后方面具有更大益处。
J Am Coll Cardiol. 2015 Sep 29;66(13):1417-27. doi: 10.1016/j.jacc.2015.07.060.
10
Randomized Trial of Stents Versus Bypass Surgery for Left Main Coronary Artery Disease: 5-Year Outcomes of the PRECOMBAT Study.随机试验：左主干冠状动脉疾病中支架治疗与旁路手术的比较：PRECOMBAT 研究 5 年结果。
J Am Coll Cardiol. 2015 May 26;65(20):2198-206. doi: 10.1016/j.jacc.2015.03.033. Epub 2015 Mar 15.